CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 54 enrolled
Drug / intervention
Visual field assessmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06539715
NCT06539715Phase 4Completed
CompareCT.gov

Comparison of Visual Field Assessments Between Three Perimeters

Gainesville Eye Associates·interventional·Posted Aug 6, 2024·Updated Apr 30, 2026

In Brief

A Phase 4 clinical trial evaluating Visual field assessment for Glaucoma. Completed, enrolled 54 participants across 1 site.

Detailed Summary

A single center, prospective, randomized, comparative study of visual field assessments between the TEMPO, VisuALL, and HFA perimeters. Subjects will be assessed at 1 visit. Clinical evaluations will include MD, PSD, FT, VFI, OCT, and a questionnaire.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
CollaboratorsSengi

Timeline

Phase 4CompletedFinished
20252026
First PostedAug 6, 2024
Enrollment StartNov 18, 2024
Primary CompletionMar 12, 2025
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 1.9 years ago

Interventions

Visual field assessmentother

Automated perimetry